The EMBER Study (Exploring Mental health Barriers in Emergency Rooms) is interested in hearing about patient experiences in the emergency department at FMC (Foothills Medical Centre). We would like to hear from you if you accessed care in the emergency department at FMC within the last year. Participation would include a brief online survey (5-10 minutes).

The Family ICU Delirium Detection Instrument (FIDDI) is a tool to help families in the ICU recognize symptoms of delirium in their loved ones. We have translated this tool into French to make it accessible to French speakers. This study aims to validate the French translation of the FIDDI. We are recruiting native or bilingual French speakers to give feedback on the French translation in one-on-one interviews offered in French and English.

CaPRI is an observational study over a five-year period. The purpose of this study is to create a Registry and Database that furthers our understanding about Parkinson’s disease (PD) and related movement disorders. The information collected will help doctors, researchers, and patients better understand how PD affects patients over time and also enable researchers to develop tests to diagnose and improve treatments for people with PD. CaPRI also aims to facilitate contact between ongoing research studies and participants who wish to contribute to the development and improvement of treatments for PD. Recently, CaPRI has partnered with the Canadian Open Parkinson Network (C-OPN) to expand its research potential Canada wide.

In this study we will recruit people who have SBMA (or are carriers) and collect health information. We will collect DNA and RNA samples for genetic analysis. We will interact with communities. Participants are encouraged to help guide the study by joining meetings with the study team.

Ischemic stroke is a serious medical emergency where every minute counts. Our research team at the Calgary Stroke Program (CSP) has developed new Artificial Intelligence (AI) tools with hopes of treating stroke patients more efficiently in Alberta. These include AI-imaging tools which aim to identify patients who need urgent stroke care by looking at their brain scans, and rapidly go through scans to find people who might need treatment. Another tool compares findings with what expert doctors find to assess AI accuracy. We want to make sure that AI-tools meet the needs of patients, their families, healthcare workers, and leaders in Alberta's health system. To do this, we are looking to recruit participants and hear about their thoughts towards AI-assistance in healthcare and stroke, so we can understand what is important to them.

We want to understand the priorities of people living with disability or dementia who have had a stroke. We are interviewing such patients along with their family-caregivers. Family-caregivers may be spouses/partners, children, or siblings. We will ask them about experiences of stroke care and life after stroke. We will include 20 pairs of patients and their family-caregivers in this study. Most stroke studies have not included people with disability or dementia. This study will help us understand how to better care for these patients. It will also help us understand how best to include them in future studies.

Adult Idiopathic Scoliosis is a common spinal deformity. Prior research showed that scoliosis-specific exercises can improve pain, quality of life, and disability but, Schroth exercises have not been tested in adults. This pilot study aims to: 1) Determine the recruitment rate; 2) Demonstrate the feasibility; and 3) Estimate the effect for all outcomes. Participants randomised to Schroth treatment will receive 5 one on one and 9 group exercise sessions over 3 months. Controls will receive the current treatment standard. We will assess changes in posture, back extensor endurance, function, pain, and quality of life. 3D Ultrasound imaging of the spine will help measure curve angles, and vertebra rotation.

The purpose of the study is to evaluate whether substance use at three Virtual Overdose Monitoring Services (VOMS) (NORS, DORS, BRAVE) that are currently operational in Alberta are associated with a change in all-cause mortality and service utilization rates among adults who are actively using substances over a two-year follow-up period.

Neuromyelitis Optica Spectrum Disorder (NMOSD) and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)are inflammatory diseases of the Central Nervous System (CNS) that are often highly disabling and challenging to treat. CANOPTICS (the CAnadian Neuromyelitis OPTIca Spectrum Disorder and other atypical demyelinating diseases Cohort Study) will allow us to gain a better understanding of the burden of NMOSD, MOGAD, and other atypical demyelinating diseases in Canada.

This is an observational patient registry with no experimental treatment, following standard of care. We will use information derived from Connect Care regarding patients with IBD under the care of Gastroenterologists who are physicians at the respective University Hospitals. The primary objective is to develop and implement an Alberta registry to collect real-world data on biologics and advanced therapies in IBD patients to facilitate research and quality improvement projects. The registry will seek to enroll all persons who either have IBD or are being evaluated for a possible diagnosis of IBD at participating sites.